期刊
LUPUS
卷 17, 期 5, 页码 405-411出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203308090025
关键词
-
类别
资金
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049772, R01AR038889] Funding Source: NIH RePORTER
- NIAMS NIH HHS [R01 AR038889-16, R01 AR049772, R01 AR038889] Funding Source: Medline
The antiphospholipid antibody syndrome (APS) is characterized by recurrent arterial and venous thrombosis and/or pregnancy in association with antiphospholipid (aPL) antibodies. The pathogenic mechanisms in APS that lead to in vivo injury are incompletely understood. Recent evidence suggests that APL antibodies alter regulation of haemostasis and induce activation of complement. We will discuss the current knowledge on how aPL antibodies trigger increased inflammation and enhanced thrombotic tendency, and thereby lead to tissue damage.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据